Back to discover
Disease

Pleural Diseases

Late-stage therapeutic developmentEmerging research
2
Publications
5
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

5 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
5
All trials
1
Active
3
Late-stage
3
Completed

Research activity

2 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20212024
Major themes4
  • Bacteria1
  • Mesothelioma1
  • Pleural Diseases1
  • Real-Time Polymerase Chain Reaction1
Leading journals2
  • Cancer discovery1
  • Microbiology spectrum1
Leading researchers8
  • Adusumilli PS1
  • Araujo Filho JA1
  • Bø B1
  • Brentjens RJ1
  • Cheema W1
  • Chintala NK1
  • Daly B1
  • Diamonte C1
Affiliations (unnormalised)6
  • Akershus University Hospital1
  • Cellular Therapeutics Center1
  • Center for Cell Engineering1
  • Department of Clinical Science1
  • Division of Medicine and Laboratory Sciences1
  • Førde Central Hospital1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Diseases involving the PLEURA.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.